Intensity Therapeutics Inc
(INTS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 02-1995 | 11-1994 | 08-1994 | 05-1994 | 02-1994 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 3,910 | 3,130 | 3,202 | 3,271 | 2,472 |
| TOTAL | $3,910 | $3,130 | $3,202 | $3,271 | $2,472 |
| Non-Current Assets | |||||
| PPE Net | 2,584 | N/A | N/A | N/A | N/A |
| Investments And Advances | 22,299 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 5,893 | 6,422 | 3,165 | 3,414 | 3,461 |
| TOTAL | $30,776 | $6,422 | $3,165 | $3,414 | $3,461 |
| Total Assets | $34,686 | $9,552 | $6,367 | $6,685 | $5,933 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,741 | 789 | 858 | 798 | 971 |
| Accrued Expenses | 5,207 | 4,559 | 3,642 | 3,361 | 4,012 |
| Other current liabilities | 6,067 | 4,949 | 5,217 | 5,272 | 5,286 |
| TOTAL | $14,967 | $11,780 | $10,616 | $10,099 | $11,544 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 200 | 181 | 197 | 212 | 222 |
| TOTAL | $200 | $1,081 | $1,097 | $1,112 | $1,122 |
| Total Liabilities | $15,167 | $12,861 | $11,713 | $11,211 | $12,666 |
| Shareholders' Equity | |||||
| Common Shares | 35,529 | 32,038 | 29,910 | 30,615 | 30,096 |
| Other shareholders' equity | -109 | -260 | -49 | -30 | 227 |
| TOTAL | $35,420 | $31,778 | $29,861 | $30,585 | $30,323 |
| Total Liabilities And Equity | $50,587 | $44,639 | $41,574 | $41,796 | $42,989 |